Heterogeneity of tumor microenvironment is associated with clinical prognosis of non-clear cell renal cell carcinoma: a single-cell genomics study

被引:11
|
作者
Chen, Wen-jin [1 ]
Cao, Hao [2 ,3 ]
Cao, Jian-wei [4 ]
Zuo, Li [5 ]
Qu, Fa-jun [4 ]
Xu, Da [1 ]
Zhang, Hao [6 ]
Gong, Hai-yi [6 ]
Chen, Jia-xin [1 ]
Ye, Jian-qing [1 ]
Gan, Si-shun [1 ]
Zhou, Wang [1 ,4 ]
Zhu, Da-wei [5 ]
Pan, Xiu-Wu [1 ,4 ]
Cui, Xin-gang [1 ,4 ]
机构
[1] Second Mil Med Univ, Affiliated Hosp 3, Dept Urol, 700 North Moyu Rd, Shanghai 201805, Peoples R China
[2] Shenyang Pharmaceut Univ, Sch Life Sci & Biopharmaceut, Shenyang 110016, Peoples R China
[3] Tsinghua Univ, Peking Tsinghua Ctr Life Sci, Beijing 100084, Peoples R China
[4] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Urol, 1665 Kongjiang Rd, Shanghai 200092, Peoples R China
[5] Nanjing Med Univ, Dept Urol, Affiliated Changzhou 2 Peoples Hosp, 29 Xinglong Rd, Changzhou 213000, Jiangsu, Peoples R China
[6] Second Mil Med Univ, Dept Orthoped Oncol, Changzheng Hosp, 415 Fengyang Rd, Shanghai 200003, Peoples R China
基金
中国国家自然科学基金;
关键词
INTRATUMORAL HETEROGENEITY; EXPRESSION; MANAGEMENT; PROTEIN;
D O I
10.1038/s41419-022-04501-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Non-clear renal cell carcinomas (nccRCCs) are less frequent in kidney cancer with histopathological heterogeneity. A better understanding of the tumor biology of nccRCC can provide more effective treatment paradigms for different subtypes. To reveal the heterogeneity of tumor microenvironment (TME) in nccRCC, we performed 10x sing-cell genomics on tumor and normal tissues from patients with papillary renal cell carcinoma (pRCC), chromophobe RCC (chrRCC), collecting duct carcinoma (CDRCC) and sarcomatoid RCC (sarRCC). 15 tissue samples were finally included. 34561 cells were identified as 16 major cell clusters with 34 cell subtypes. Our study presented the sing-cell landscape for four types of nccRCC, and demonstrated that CD8+ T cells exhaustion, tumor-associated macrophages (TAMs) and sarcomatoid process were the pivotal factors in immunosuppression of nccRCC tissues and were closely correlated with poor prognosis. Abnormal metabolic patterns were present in both cancer cells and tumor-infiltrating stromal cells, such as fibroblasts and endothelial cells. Combined with CIBERSORTx tool, the expression data of bulk RNA-seq from TCGA were labeled with cell types of our sing-cell data. Calculation of the relative abundance of cell types revealed that greater proportion of exhausted CD8+ T cells, TAMs and sarRCC derived cells were correlated with poor prognosis in the cohort of 274 nccRCC patients. To the best of our knowledge, this is the first study that provides a more comprehensive sight about the heterogeneity and tumor biology of nccRCC, which may potentially facilitate the development of more effective therapies for nccRCC.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Characteristics and Treatment Challenges of Non-Clear Cell Renal Cell Carcinoma
    Sepe, Pierangela
    Ottini, Arianna
    Pircher, Chiara Carlotta
    Franza, Andrea
    Claps, Melanie
    Guadalupi, Valentina
    Verzoni, Elena
    Procopio, Giuseppe
    CANCERS, 2021, 13 (15)
  • [32] Targeted therapies and the treatment of non-clear cell renal cell carcinoma
    Bellmunt, J.
    Dutcher, J.
    ANNALS OF ONCOLOGY, 2013, 24 (07) : 1730 - 1740
  • [33] Cabozantinib and dasatinib synergize to induce tumor regression in non-clear cell renal cell carcinoma
    Lue, Hui-wen
    Derrick, Daniel S.
    Rao, Soumya
    Van Gaest, Ahna
    Cheng, Larry
    Podolak, Jennifer
    Lawson, Samantha
    Xue, Changhui
    Garg, Devin
    White, Ralph I. I. I. I. I. I.
    Ryan, Christopher W.
    Drake, Justin M.
    Ritz, Anna
    Heiser, Laura M.
    Thomas, George, V
    CELL REPORTS MEDICINE, 2021, 2 (05)
  • [34] Decoding the Immune Microenvironment of Clear Cell Renal Cell Carcinoma by Single-Cell Profiling to Aid Immunotherapy
    Liu, Jie
    Xu, Jiangfan
    Zhang, Tong
    Xu, Kailong
    Bao, Peihua
    Zhang, Zhibo
    Xue, Kaiwen
    He, Ruyi
    Ma, Lixin
    Wang, Yang
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma
    Wan, Zhengqiang
    Wang, Yinglei
    Li, Aiqun
    Li, Cheng
    Zheng, Dongbing
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [36] FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
    Zhong, Guanghui
    Li, Qing
    Luo, Yang
    Liu, Yufeng
    Liu, Dawei
    li, Bin
    Wang, Tao
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [37] Targeted therapies for non-clear renal cell carcinoma
    Eric A. Singer
    Gennady Bratslavsky
    W. Marston Linehan
    Ramaprasad Srinivasan
    Targeted Oncology, 2010, 5 : 119 - 129
  • [38] Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma
    Armstrong, Andrew J.
    Nixon, Andrew B.
    Carmack, Andrea
    Yang, Qian
    Eisen, Tim
    Stadler, Walter M.
    Jones, Robert J.
    Garcia, Jorge A.
    Vaishampayan, Ulka N.
    Picus, Joel
    Hawkins, Robert E.
    Hainsworth, John D.
    Kollmannsberger, Christian K.
    Logan, Theodore F.
    Puzanov, Igor
    Pickering, Lisa M.
    Ryan, Christopher W.
    Protheroe, Andrew
    George, Daniel J.
    Halabi, Susan
    CLINICAL CANCER RESEARCH, 2021, 27 (12) : 3317 - 3328
  • [39] Targeted therapies for non-clear renal cell carcinoma
    Singer, Eric A.
    Bratslavsky, Gennady
    Linehan, W. Marston
    Srinivasan, Ramaprasad
    TARGETED ONCOLOGY, 2010, 5 (02) : 119 - 129
  • [40] Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma
    Anwaier, Aihetaimujiang
    Xu, Wenhao
    Liu, Wangrui
    Wei, Shiyin
    Tian, Xi
    Qu, Yuanyuan
    Yang, Jianfeng
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL OF THE NATIONAL CANCER CENTER, 2023, 3 (03): : 236 - 249